Appili Therapeutics, Inc. (APLIF)
0.0055
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
Appili Therapeutics EPS Diluted (Quarterly) : -0.0093 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0093 |
| March 31, 2026 | -0.0058 |
| December 31, 2025 | -0.0053 |
| September 30, 2025 | -0.0059 |
| June 30, 2025 | -0.0074 |
| March 31, 2025 | 0.0014 |
| December 31, 2024 | -0.0031 |
| September 30, 2024 | -0.0045 |
| June 30, 2024 | -0.0096 |
| March 31, 2024 | -0.0067 |
| December 31, 2023 | -0.0009 |
| September 30, 2023 | -0.006 |
| June 30, 2023 | -0.0095 |
| March 31, 2023 | -0.0162 |
| December 31, 2022 | -0.0159 |
| September 30, 2022 | -0.0103 |
| June 30, 2022 | -0.02 |
| Date | Value |
|---|---|
| March 31, 2022 | -0.0369 |
| December 31, 2021 | -0.0367 |
| September 30, 2021 | -0.1412 |
| June 30, 2021 | -0.0956 |
| March 31, 2021 | -0.0627 |
| December 31, 2020 | -0.0523 |
| September 30, 2020 | -0.0302 |
| June 30, 2020 | -0.0373 |
| March 31, 2020 | -0.0206 |
| December 31, 2019 | -0.0266 |
| September 30, 2019 | -0.0259 |
| June 30, 2019 | -0.0444 |
| March 31, 2019 | -0.0325 |
| December 31, 2018 | -0.0302 |
| March 31, 2018 | -0.0369 |
| December 31, 2017 | -0.0265 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -1.434 |
| NervGen Pharma Corp. | -0.2283 |
| Milestone Pharmaceuticals, Inc. | -0.2063 |
| Clearmind Medicine, Inc. | -0.5734 |
| Lexaria Bioscience Corp. | -1.204 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.228M |
| Revenue (Quarterly) | 0.0852M |
| Total Expenses (Quarterly) | 1.313M |
| Enterprise Value | 10.02M |
| Gross Profit Margin (Quarterly) | 98.83% |
| Profit Margin (Quarterly) | -1.44K% |
| Earnings Yield | -478.2% |
| Normalized Earnings Yield | -478.18 |